Mission and Measuring Our Impact
Cures Within Reach improves patient quality and length of life by leveraging the speed, safety and cost-effectiveness of medical repurposing research, driving more treatments to more patients more quickly.
Cures is the philanthropic leader in drug, device and nutraceutical repurposing research, which has the potential to transform the lives of patients with unsolved diseases by delivering treatments that can be used in the near-term.
Our Functions
Value Driving Catalyst
• Bringing stakeholders together to undertake repurposing research opportunities
Value Driving Facilitator
• Building, managing and growing CureAccelerator as a central repurposing platform and creating other opportunities to bring together repurposing research stakeholders
• Fostering collaboration and conversation to create market impact and health savings, including new economic incentives for the repurposing of generic drugs
Our Success Stories and Case Studies
Our facilitated research has created more than 13 treatments in use by patients today or funded for larger confirmatory clinical trials.
Repurposing a Generic Tuberculosis Vaccine to Treat Type 1 Diabetes
Repurposing a Transplant Drug Saves Kids with ALPS, a Rare but Deadly Blood Disorder
Repurposing a Liver Cyst Laser Device to Eliminate Side Effects of Prostate Cancer Treatment
Repurposing a Device to Help Restore Function Lost to Brain and Nerve Disorders
CureAccelerator
In 2015, we launched CureAccelerator, the world’s first interactive, online platform dedicated to repurposing research. By connecting researchers, funders, the biomedical industry and patient groups, CureAccelerator drives the pace of repurposing research, to drive more treatments to more patients more quickly.
Our History
In 1998, Goldman Philanthropic Partners (GPP), a private operating foundation, was founded to accelerate the discovery of new treatments to improve the quality of life for people with catastrophic diseases. In 2005, Partnership for Cures was established as a 501(c)(3) public charity to carry on the GPP mission, bringing hope and supporting new directions through Rediscovery Research™ and in 2012, we changed our name to Cures Within Reach.
Our commitment as an organization has always been:
Alleviating suffering and bringing hope to those dealing with life-threatening illness.
Challenging research institutions to support alternative approaches for research and funding that may lead to medical breakthroughs.
Inspiring and funding researchers with innovative ideas that might otherwise remain unexplored.
Honoring a donor's unique motivation to have an impact on the pursuit of treatments and cures.
Founder; currently Chief Collaboration Officer, Healx
Bruce Bloom, DDS, JD (led Partnership For Cures dba Cures Within Reach from 2005-2019)
Dr. Bruce Bloom is currently the Chief Collaboration Officer of Healx. In February 2002, he became the Executive Director of Goldman Philanthropic Partnerships, a 501(c)(3) private operating foundation. In 2005, when Goldman Partnerships created the public charity Partnership for Cures to carry on the Goldman mission, Bruce became its President and Chief Science Officer. In October 2012, Partnership for Cures changed its name to Cures Within Reach to better reflect the focus of its mission: repurposing drugs and other treatments to drive more treatments to more patients more quickly. In 2017, Bruce became CEO of Cures Within Reach and in 2019, he left to pursue other opportunities.
